Who owns the LUROXENT trademark?

The LUROXENT trademark is owned by Glaxo Group Limited.

What class is the LUROXENT trademark registered in?

The LUROXENT trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for LUROXENT?

The USPTO serial number for LUROXENT is 79261523.

What is the registration number for LUROXENT?

LUROXENT is registered under USPTO registration number 5964210.

Sealvo

Home Search: LUROXENTLUROXENT #79261523

Back

Updated Oct 10, 2026·41 searches this week

View on USPTO TSDR Find similar marks

LUR

USPTO Trademark Record

ABANDONED

LUROXENT

SN 79261523·Reg 5964210·Filed May 16, 2019

Owner Glaxo Group Limited

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

LUROXENT (Serial No. 79261523), Registration No. 5964210, is a abandoned US trademark filed on May 16, 2019 by Glaxo Group Limited. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

LUROXENT (Reg. #5964210) is an abandoned US trademark that was filed in 2019 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

May 16, 2019

SERIAL

79261523

REG#

5964210

REGISTERED

Jan 21, 2020

Filing Information

StatusABANDONED

Filing DateMay 16, 2019

Serial Number79261523

Registration No.5964210

Registration DateJan 21, 2020

Status DateAug 07, 2026

Published for OppositionNov 05, 2019

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

29 events

CANCELLED SECTION 71

Aug 07, 2026

CANCELLED SECTION 71

NEW REPRESENTATIVE AT IB RECEIVED

May 30, 2025

NEW REPRESENTATIVE AT IB RECEIVED

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Jan 21, 2025

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

CHANGE OF NAME/ADDRESS REC'D FROM IB

Jul 28, 2023

CHANGE OF NAME/ADDRESS REC'D FROM IB

FINAL DECISION TRANSACTION PROCESSED BY IB

May 22, 2020

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Apr 30, 2020

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Apr 30, 2020

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Apr 21, 2020

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Jan 21, 2020

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Nov 05, 2019

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 05, 2019

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Nov 02, 2019

NOTIFICATION PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Oct 16, 2019

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Oct 16, 2019

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Oct 16, 2019

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

ASSIGNED TO LIE

Sep 30, 2019

ASSIGNED TO LIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 24, 2019

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 23, 2019

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 23, 2019

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 23, 2019

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Aug 16, 2019

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Jul 27, 2019

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jul 27, 2019

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jul 06, 2019

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Jul 05, 2019

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Jul 04, 2019

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Jul 02, 2019

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 28, 2019

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Jun 27, 2019

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by Glaxo Group Limited

Additional USPTO filings from the same owner.

KOS

KOSPRIZTO

99535749

Glaxo Group Limited

REGISTERED

KYB

KYBRAKU

99535750

Glaxo Group Limited

REGISTERED

EQP

EQPANZO

99535752

Glaxo Group Limited

REGISTERED

HON

HONMOZA

99535758

Glaxo Group Limited

REGISTERED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

LUR

LUROXENT

99845906

Glaxo Group Limited

REGISTERED

Other Marks by Merilee J. Arevalo

Additional USPTO filings handled by the same attorney of record.

VII

VIIV HEALTHCARE

90781713

REGISTERED

VII

VIIV HEALTHCARE

90781712

REGISTERED

DEX

DEXUVE

79261531

REGISTERED

KOM

KOMRILU

79280370

REGISTERED

LUROXENT

Run a conflict check

Other Marks by Glaxo Group Limited

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Merilee J. Arevalo

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company